Improved Adverse Drug Event Prediction Through Information Component Guided Pharmacological Network Model (IC-PNM)
dc.contributor.author | Ji, Xiangmin | |
dc.contributor.author | Wang, Lei | |
dc.contributor.author | Hua, Liyan | |
dc.contributor.author | Wang, Xueying | |
dc.contributor.author | Zhang, Pengyue | |
dc.contributor.author | Shendre, Aditi | |
dc.contributor.author | Feng, Weixing | |
dc.contributor.author | Li, Jin | |
dc.contributor.author | Li, Lang | |
dc.contributor.department | Biostatistics and Health Data Science, Richard M. Fairbanks School of Public Health | |
dc.date.accessioned | 2024-10-21T11:14:15Z | |
dc.date.available | 2024-10-21T11:14:15Z | |
dc.date.issued | 2021 | |
dc.description.abstract | Improving adverse drug event (ADE) prediction is highly critical in pharmacovigilance research. We propose a novel information component guided pharmacological network model (IC-PNM) to predict drug-ADE signals. This new method combines the pharmacological network model and information component, a Bayes statistics method. We use 33,947 drug-ADE pairs from the FDA Adverse Event Reporting System (FAERS) 2010 data as the training data, and the new 21,065 drug-ADE pairs from FAERS 2011-2015 as the validations samples. The IC-PNM data analysis suggests that both large and small sample size drug-ADE pairs are needed in training the predictive model for its prediction performance to reach an area under the receiver operating characteristic curve (\textAUROC)= 0.82(AUROC)=0.82. On the other hand, the IC-PNM prediction performance improved to \textAUROC= 0.91AUROC=0.91 if we removed the small sample size drug-ADE pairs from the prediction model during validation. | |
dc.eprint.version | Final published version | |
dc.identifier.citation | Ji X, Wang L, Hua L, et al. Improved Adverse Drug Event Prediction Through Information Component Guided Pharmacological Network Model (IC-PNM). IEEE/ACM Transactions on Computational Biology and Bioinformatics. 2021;18(3):1113-1121. doi:10.1109/TCBB.2019.2928305 | |
dc.identifier.uri | https://hdl.handle.net/1805/44093 | |
dc.language.iso | en_US | |
dc.publisher | IEEE | |
dc.relation.isversionof | 10.1109/TCBB.2019.2928305 | |
dc.relation.journal | IEEE/ACM Transactions on Computational Biology and Bioinformatics | |
dc.rights | Attribution 4.0 International | en |
dc.rights.uri | https://creativecommons.org/licenses/by/4.0 | |
dc.source | Publisher | |
dc.subject | Adverse drug event | |
dc.subject | Biological system modeling | |
dc.subject | Data models | |
dc.subject | Databases | |
dc.subject | Drugs | |
dc.subject | Information component | |
dc.subject | Integrated circuits | |
dc.subject | Pharmacological network model | |
dc.subject | Pharmacovigilance | |
dc.subject | Predictive models | |
dc.subject | Training data | |
dc.title | Improved Adverse Drug Event Prediction Through Information Component Guided Pharmacological Network Model (IC-PNM) | |
dc.type | Article |